Fundraising FoxSB TEMPUS
Tokyo, JP · 1 known investors
Find your way into SB TEMPUS
285 people in our graph can introduce you to the SB TEMPUS team.
Sign up to see every warm intro you have to SB TEMPUS
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SB TEMPUS team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SB TEMPUS supports personalized medicine for cancer treatment by integrating medical data and AI. The company offers genetic testing, medical data utilization, and AI applications serving healthcare institutions, pharmaceutical companies, and biotech ventures.
Founders & leadership
柴和
柴山 和久Director, CTO
松健
松井 健太郎Representative Director, President and CEO
RF
Ryan FukushimaRepresentative DirectorRyan Fukushima was the first employee at Tempus AI and contributed to scaling the company through its IPO, later leading the Data & Apps division. He is also cofounder and former CEO of Pathos AI, which focuses on applying AI to drug development and precision oncology.
筒多
筒井 多圭志Director, Chief Scientist
Board
AP
Andy PolovinBoard director
JR
Jim RogersBoard director
Investors · 1
Frequently asked questions
- What does SB TEMPUS do?
- SB TEMPUS supports personalized medicine for cancer treatment by integrating medical data and AI. The company offers genetic testing, medical data utilization, and AI applications serving healthcare institutions, pharmaceutical companies, and biotech ventures.
- Who are SB TEMPUS's investors?
- SB TEMPUS's investors include SoftBank Group.
- Where is SB TEMPUS headquartered?
- SB TEMPUS is headquartered in Tokyo, JP.